Journal of the American Academy of Dermatology
Volume 59, Issue 3 , Pages 405-417 , September 2008

Outcomes of melanoma in recipients of solid organ transplant

  • Daniel C. Dapprich, MD

      Affiliations

    • Department of Dermatology, Mayo Clinic, Rochester, Minnesota
    • ,
  • Roger H. Weenig, MD

      Affiliations

    • Department of Dermatology, Mayo Clinic, Rochester, Minnesota
    • ,
  • Audrey L. Rohlinger, BS

      Affiliations

    • Division of Biostatistics, Mayo Clinic, Rochester, Minnesota
    • ,
  • Amy L. Weaver, MS

      Affiliations

    • Division of Biostatistics, Mayo Clinic, Rochester, Minnesota
    • ,
  • Katherine K. Lim Quan, MD

      Affiliations

    • Department of Dermatology, Mayo Clinic, Rochester, Minnesota
    • ,
  • James H. Keeling, MD

      Affiliations

    • Department of Dermatology, Mayo Clinic, Jacksonville, Florida
    • ,
  • John S. Walsh, MD

      Affiliations

    • Department of Dermatology, Mayo Clinic, Jacksonville, Florida
    • ,
  • Clark C. Otley, MD

      Affiliations

    • Department of Dermatology, Mayo Clinic, Rochester, Minnesota
    • Corresponding Author InformationReprint requests: Clark C. Otley, MD, Department of Dermatology, Mayo Clinic, 200 First St SW, Rochester, MN 55905.
    • ,
  • Leslie J. Christenson, MD

      Affiliations

    • Department of Dermatology, Mayo Clinic, Rochester, Minnesota

,Accepted 13 May 2008.

References 

  1. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19:3635–3648
  2. Clemente CG, Mihm MC, Bufalino R, Zurrida S, Collini P, Cascinelli N. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer. 1996;77:1303–1310
  3. Menzies SW, McCarthy WH. Complete regression of primary cutaneous malignant melanoma. Arch Surg. 1997;132:553–556
  4. Halliday GM, Patel A, Hunt MJ, Tefany FJ, Barnetson RS. Spontaneous regression of human melanoma/nonmelanoma skin cancer: association with infiltrating CD4+ T cells. World J Surg. 1995;19:352–358
  5. Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Rivoltini L, Topalian SL, et al. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci U S A. 1994;91:3515–3519
  6. Marshall JA, Forster TH, Purdie DM, Lanagan CM, O'Connor LE, O'Rourke MG, et al. Immunological characteristics correlating with clinical response to immunotherapy in patients with advanced metastatic melanoma. Immunol Cell Biol. 2006;84:295–302
  7. Lindelof B, Sigurgeirsson B, Gabel H, Stern RS. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol. 2000;143:513–519
  8. Le Mire L, Hollowood K, Gray D, Bordea C, Wojnarowska F. Melanomas in renal transplant recipients. Br J Dermatol. 2006;154:472–477
  9. Rodrigues LK, Klencke BJ, Vin-Christian K, Berger TG, Crawford RI, Miller JF, et al. Altered clinical course of malignant melanoma in HIV-positive patients. Arch Dermatol. 2002;138:765–770
  10. McKenna DB, Stockton D, Brewster DH, Doherty VR. Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland. Br J Cancer. 2003;88:74–78
  11. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med. 2000;342:605–612
  12. Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl. 1994;99–109
  13. National Cancer Institute. 51-Year trends in US cancer death rates: SEER cancer statistics review, 1975-2000. Available from: URL:http://seer.cancer.gov/csr/1975_2000/results_merged/topic_inc_mor_trends.pdf. Accessed May 10, 2006.
  14. de Vries E, Bray FI, Coebergh JW, Parkin DM. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer. 2003;107:119–126
  15. Stang A, Jockel KH. Changing patterns of skin melanoma mortality in West Germany from 1968 through 1999. Ann Epidemiol. 2003;13:436–442
  16. Coory M, Baade P, Aitken J, Smithers M, McLeod GR, Ring I. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002. Cancer Causes Control. 2006;17:21–27
  17. Baade P, Coory M. Trends in melanoma mortality in Australia: 1950-2002 and their implications for melanoma control. Aust N Z J Public Health. 2005;29:383–386
  18. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. New TNM melanoma staging system: linking biology and natural history to clinical outcomes. Semin Surg Oncol. 2003;21:43–52
  19. Cassarino DS, Cabral ES, Kartha RV, Swetter SM. Primary dermal melanoma: distinct immunohistochemical findings and clinical outcome compared with nodular and metastatic melanoma. Arch Dermatol. 2008;144:49–56
  20. Penn I. Malignant melanoma in organ allograft recipients. Transplantation. 1996;61:274–278
  21. Leveque L, Dalac S, Dompmartin A, Louvet S, Euvrard S, Catteau B, et al. Melanoma in organ transplant patients. [in French] Ann Dermatol Venereol. 2000;127:160–165
  22. Greene MH, Young TI, Clark WH. Malignant melanoma in renal-transplant recipients. Lancet. 1981;1:1196–1199
  23. Oliver RT, Nouri AM. T cell immune response to cancer in humans and its relevance for immunodiagnosis and therapy. Cancer Surv. 1992;13:173–204
  24. Lee PP, Yee C, Savage PA, Fong L, Brockstedt D, Weber JS, et al. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat Med. 1999;5:677–685
  25. Neri B, Vannozzi L, Fulignati C, Pantaleo P, Pantalone D, Paoletti C, et al. Long-term survival in metastatic melanoma patients treated with sequential biochemotherapy: report of a phase II study. Cancer Invest. 2006;24:474–478
  26. Herman M, Weinstein T, Korzets A, Chagnac A, Ori Y, Zevin D, et al. Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients. J Lab Clin Med. 2001;137:14–20
  27. Hojo M, Morimoto T, Maluccio M, Asano T, Morimoto K, Lagman M, et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature. 1999;397:530–534
  28. Maluccio M, Sharma V, Lagman M, Vyas S, Yang H, Li B, et al. Tacrolimus enhances transforming growth factor-β1 expression and promotes tumor progression. Transplantation. 2003;76:597–602
  29. Geissler EK, Schlitt HJ. The relation between immunosuppressive agents and malignancy. Curr Opin Organ Transplant. 2004;9:394–399
  30. Goldstein AM, Tucker MA. Genetic epidemiology of familial melanoma. Dermatol Clin. 1995;13:605–612
  31. Haluska FG, Hodi FS. Molecular genetics of familial cutaneous melanoma. J Clin Oncol. 1998;16:670–682
  32. Benvenuto-Andrade C, Oseitutu A, Agero AL, Marghoob AA. Cutaneous melanoma: surveillance of patients for recurrence and new primary melanomas. Dermatol Ther. 2005;18:423–435
  33. Penn I. Transmission of cancer from organ donors. Ann Transplant. 1997;2:7–12
  34. Stephens JK, Everson GT, Elliott CL, Kam I, Wachs M, Haney J, et al. Fatal transfer of malignant melanoma from multiorgan donor to four allograft recipients. Transplantation. 2000;70:232–236
  35. Morris-Stiff G, Steel A, Savage P, Devlin J, Griffiths D, Portman B, et al. Welsh Transplantation Research Group. Transmission of donor melanoma to multiple organ transplant recipients. Am J Transplant. 2004;4:444–446
  36. MacKie RM, Reid R, Junor B. Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery. N Engl J Med. 2003;348:567–568
  37. Birkeland SA, Storm HH. Risk for tumor and other disease transmission by transplantation: a population-based study of unrecognized malignancies and other diseases in organ donors. Transplantation. 2002;74:1409–1413
  38. Buell JF, Trofe J, Hanaway MJ, Lo A, Rosengard B, Rilo H, et al. Transmission of donor cancer into cardiothoracic transplant recipients. Surgery. 2001;130:660–666
  39. Weinstock MA, Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE. Recall (report) bias and reliability in the retrospective assessment of melanoma risk. Am J Epidemiol. 1991;133:240–245

 Funding sources: None.

 Conflicts of interest: None declared.

PII: S0190-9622(08)00608-7

doi: 10.1016/j.jaad.2008.05.015

Journal of the American Academy of Dermatology
Volume 59, Issue 3 , Pages 405-417 , September 2008

Article Tools

* Image Usage & Resolution